The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.
Status after myocardial infarction (minimum 3 months before inclusion in the study).
Documented post-infarction VT or VF.
Implantable ICD (at least 2 weeks before ablation) or CRT-D (at least 2 months before ablation).
One or more high energy interventions.
Obesity with BMI > 40 kg/m2.
Left ventricle ejection fraction < 20%.
Pregnancy or breastfeeding.
Renal failure (eGFR < 20 mL/min/1.73m2).
MEDICOVER SP Z O.O.
Lead sponsor
National Institute of Cardiology, Warsaw, Poland
Collaborator
Medical University of Warsaw
Collaborator